Anthony Quinn Insider Trading
Get free email notifications about insider trading for Anthony Quinn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anthony Quinn. Anthony Quinn is a EVP, CMO & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and a EVP, CMO, & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and a Director in Aeglea BioTherapeutics, Inc. ($AGLE) and a Interim CEO in Aeglea BioTherapeutics, Inc. ($AGLE) and a interim Chief Medical Officer in Aeglea BioTherapeutics, Inc. ($AGLE) and a President & CEO in Aeglea BioTherapeutics, Inc. ($AGLE) and a Director in Generation Bio Co. ($GBIO) and a Director in Kaleido Biosciences, Inc. ($KLDO).
Address: C/O SYNAGEVA BIOPHARMA 128 SPRING STREET LEXINGTON 02421 MA
Companies in which Anthony Quinn is an Insider
Aeglea BioTherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anthony Quinn: President & CEO, Interim CEO, interim Chief Medical Officer, Director
Holdings: 538,469 shares
Current Value: $2,256,185
Latest Transaction: Feb 19 2021
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Generation Bio Co.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anthony Quinn: Director
Holdings: 72,837 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kaleido Biosciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anthony Quinn: Director
Holdings: 31,603 shares
Latest Transaction: Jul 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anthony Quinn: EVP, CMO, & Head of R&D, EVP, CMO & Head of R&D
Holdings: 0 shares
Latest Transaction: Jun 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Anthony Quinn
Sentiment: All, AGLE, GBIO, KLDO, GEVA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 7.35 | 330,000 | 2,425,500 | 330,000 | |
| Jul 01 2020 | KLDO | Kaleido Bioscience ... | Quinn Anthony G. | Director | Option Exercise | A | 7.43 | 15,000 | 111,450 | 15,000 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Quinn Anthony G. | Director | Option Exercise | C | 0.00 | 53,654 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Quinn Anthony G. | Director | Buy | C | 0.00 | 30,376 | 0 | 72,837 | 42.5 K to 72.8 K (+71.54 %) |
| Jun 15 2020 | GBIO | Generation Bio Co. | Quinn Anthony G. | Director | Option Exercise | A | 19.00 | 52,000 | 988,000 | 52,000 | |
| May 04 2020 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 4.75 | 165,000 | 783,750 | 538,469 | 373.5 K to 538.5 K (+44.18 %) |
| Feb 19 2020 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 8.15 | 301,000 | 2,453,150 | 301,000 |